PRQR

ProQR Therapeutics N.V.

Healthcare · Biotechnology

$123.61 sample

-1.54 (-1.23%) 1D

Market cap

$205.7B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-21

Alerts

8

Price$123.61 +7.11% 3M daily closessample

125.15111.25

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: Chief Financial Officer
Oct 02INSInsider sell: Director
Sep 25INSInsider sell: EVP, Operations
Sep 21SEC10-Q filed
Sep 11INSInsider buy: 10% owner
Sep 08INSInsider buy: Chief Financial Officer
Sep 01INSInsider sell: Chief Financial Officer
Aug 24INSInsider sell: General Counsel

Sign up to see the real PRQR record →

Company facts

SEC EDGAR registration

Name: ProQR Therapeutics N.V.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +4sample, -100 to +100
Reporting currency: USD

Who is positioning in PRQR

sample

Insiders: 17 insider transactions over 90 days, net selling, $455.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 40 funds hold $1.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$10.5B +18.0% y/y

Q4 2024Q3 2026

Inventory$6.5B +13.7% y/y

Q4 2024Q3 2026

Accounts receivable$5.0B +15.2% y/y

Q4 2024Q3 2026

Total debt$13.2B +15.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $157.5B +9.2% 3M
Sample peer B: $121.7B +4.6% 3M
Sample peer C: $135.6B -3.2% 3M
Sample peer D: $27.1B +12.6% 3M
Sample peer E: $22.5B -10.3% 3M